The regulatory file for yeast beta-glucan
Yeast β-glucan sits where a food ingredient, a supplement ingredient and a claim meet. The file has to show the source, the method and the lot, and then show how the destination market permits the material and the wording. Health claims are restricted, so the buyer's regulatory team confirms the route for the product and the market.
A β-glucan file is source-specific: the yeast record, the enzymatic method and the claim must match the market, and no certificate can settle that question alone.
What the file contains
Think of the file as a chain with four links. The first names the material and the specification revision being bought. The second identifies the lot and reports what its certificate measured. The third applies the destination's limits, labelling rules and claim rules to the finished product. The fourth records what happens when the yeast, the process or the pack changes. A COA answers the lot link, a technical data sheet answers the specification link, and a safety data sheet covers handling. None of the three answers the market link.
For this material the source record is part of the chain, not an appendix. The file should identify the yeast, the fermentation and the cell-wall separation, because the β-glucan figure alone does not say whether the powder is a yeast extract, an oat concentrate or a fungal preparation. The analytical procedure belongs in the same record: a percentage without its method cannot be reviewed.
European Union
EU food law starts with responsibility: the operator that places the material on the market must be able to show that it is safe and correctly described. Regulation (EC) No 178/2002 and the labelling rules in Regulation (EU) No 1169/2011 set that frame. Contaminants are controlled through Regulation (EU) 2023/915, which replaced the earlier consolidated regulation; the version in force on the shipment date is the one that matters, not a summary from an older file.
Novel-food status is a separate question and must be answered for the destination. Some markets have a product-specific entry for a defined yeast β-glucan; confirm the current text and the conditions that go with it. The buyer's regulatory team makes that call. A supplier's statement that the powder is “food grade” is a quality statement, not a novel-food route.
United States
In the US the usual framework is the dietary-supplement route, with the finished product manufactured under the cGMP rules in 21 CFR 111. If the ingredient was not on the market as a dietary ingredient before 1994, a new dietary ingredient notification under 21 U.S.C. 350b may be needed. The supplier ought to identify the basis it depends on and show the document behind it; an offer that leaves this to the buyer is incomplete.
The Supplement Facts panel names the ingredient as sold, including its source and quantity. A structure/function statement carries its own rules and disclaimer, and a health claim goes through a different review. The buyer checks that the basis covers the finished product, the dose and the exact wording. Approval of a claim is not part of the certificate.
Contaminants and limits
Contaminant compliance is calculated on the finished product, not only on the drum. The values below are the catalog gates; the destination text and the daily dose determine the final limit that applies.
| Item | Catalog gate | Evidence the file should hold |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Lot result, analytical method and dose calculation |
| Arsenic (As) | ≤2 mg/kg | Lot result and the market-specific limit |
| Cadmium (Cd) | ≤1 mg/kg | Lot result and the source record |
| Mercury (Hg) | ≤0.1 mg/kg | Lot result and method |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Counts and absence findings for the lot |
| Moisture and ash | Moisture ≤6.0%; ash ≤3.0% | Measured figures beside the β-glucan result |
Label and claims
Health claims are restricted. In the EU a health claim must be authorised and appear in the EU Register under Regulation (EC) No 1924/2006. The beta-glucan claim found there is written for oat and barley β-glucan and a defined daily intake. A yeast 1,3/1,6 ingredient does not inherit that wording merely because its assay is high. The buyer's regulatory team decides whether any claim is available for this source, this product and this destination.
In the US, a structure/function statement and a health claim are reviewed on different tracks, and a disease claim falls outside the supplement framework. The label should name the material and its source accurately, and the claim review belongs in the label file. A claim cannot rewrite the specification, and a COA cannot authorise a claim.
Documents the file needs
- Lot COA with the β-glucan procedure, the basis and the contaminant results.
- Current technical data sheet and the specification revision it belongs to.
- Safety data sheet for handling and transport.
- Source record covering yeast strain, fermentation and cell-wall separation.
- Allergen statement for the fermentation source and any carrier, plus a GMO statement.
- Origin statement and, where relevant, a residual-solvent statement.
- A method description that another laboratory could repeat.
- Food-grade statement and the heavy-metal and microbiology findings.
Version numbers turn a pile of PDFs into a file. If a statement is missing for a lot, identify the gap before the order is placed; discovering it during import clearance is more expensive.
Checklist before the first order
- Specification revision, CAS 9041-22-9, yeast source and linkage are written down.
- The β-glucan procedure and basis agree across specification, COA and label.
- Contaminant figures are recalculated for the daily dose of the finished product.
- The buyer's regulatory team has recorded the route for the destination.
- Label, source description and claim have been reviewed as one package.
- Yeast, process and pack are under change control.
Catalog figures are on the beta-glucan hub; the lot certificate is explained on the COA page; the analytical evidence is on the identity page; the chitosan page shows a parallel file for another source-dependent polymer; the methods library describes the tests; the quality page covers the release file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation